Literature DB >> 10533470

The prognosis of small primary breast cancers.

J Kollias1, C A Murphy, C W Elston, I O Ellis, J F Robertson, R W Blamey.   

Abstract

The Nottingham Prognostic Index (NPI) is an integrated prognostic index used to predict patient survival for women with invasive breast cancer. The index is based on invasive tumour size, histological lymph node stage and tumour grade. The value of such an index has been questioned in small invasive breast cancers and it has been suggested that size is the only necessary prognostic determinant. The aims of this study were to determine the extent of regional lymph node involvement and survival in women with small invasive breast cancers and to assess the value of the NPI. Between 1976 and 1994, 2684 women aged < or = 70 years were treated for primary operable invasive breast cancers of < or = 5 cm in maximum diameter, of which 318 measured < or = 1 cm. Follow-up data were evaluated to determine histological factors important in predicting survival outcomes in women with cancers < or = 1 cm in diameter and comparing their survival according to the NPI with all women treated for primary operable breast cancers < or = 5 cm in maximum diameter. Histological lymph node involvement was demonstrated in 56/318 (18%) of cancers of < or = 1 cm in diameter. Significant survival differences were demonstrated for small breast cancers according to lymph node stage, vascular invasion and histological tumour grade. Only lymph node stage and histological tumour grade were independent prognostic indicators using a multivariate Cox model. The survival curves for small tumours stratified by the NPI were similar to those of cancers up to 5 cm in diameter. The results indicate that lymph node staging and histological grading are still important prognostic determinants for breast cancers < or = 1 cm in diameter. An axillary node staging procedure should be performed for all invasive breast cancers < or = 1 cm in diameter. The NPI remains relevant for small breast cancers.

Entities:  

Mesh:

Year:  1999        PMID: 10533470     DOI: 10.1016/s0959-8049(99)00056-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  17 in total

1.  Clinicopathological features and prognosis of pregnancy associated breast cancer - a matched case control study.

Authors:  Lilla Madaras; Kristóf Attila Kovács; Attila Marcell Szász; István Kenessey; Anna-Mária Tőkés; Borbála Székely; Zsuzsanna Baranyák; Orsolya Kiss; Magdolna Dank; Janina Kulka
Journal:  Pathol Oncol Res       Date:  2013-12-20       Impact factor: 3.201

Review 2.  The value of adjuvant treatment in young women with breast cancer.

Authors:  Sally Clive; J Michael Dixon
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma.

Authors:  S Frkovic-Grazio; M Bracko
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

4.  Association of SPARC gene polymorphisms rs3210714 and rs7719521 with VEGF expression and utility of Nottingham Prognostic Index scoring in breast cancer in a sample of Egyptian women.

Authors:  Sultan Bawazeer; Dina Sabry; Rania H Mahmoud; Hala M Elhanbuli; Noha N Yassen; Marwa N Abdelhafez
Journal:  Mol Biol Rep       Date:  2018-09-27       Impact factor: 2.316

5.  Immunohistochemical prognostic index for breast cancer in young women.

Authors:  I Guerra; J Algorta; R Díaz de Otazu; A Pelayo; J Fariña
Journal:  Mol Pathol       Date:  2003-12

6.  Should Histologic Grade Be Incorporated into the TNM Classification System for Small (T1, T2) Node-Negative Breast Adenocarcinomas?

Authors:  Mathew Purdom; Michael L Cibull; Terry D Stratton; Luis M Samayoa; Edward H Romond; Patrick C McGrath; Rouzan G Karabakhtsian
Journal:  Patholog Res Int       Date:  2010-10-26

Review 7.  Breast cancer prognostic classification in the molecular era: the role of histological grade.

Authors:  Emad A Rakha; Jorge S Reis-Filho; Frederick Baehner; David J Dabbs; Thomas Decker; Vincenzo Eusebi; Stephen B Fox; Shu Ichihara; Jocelyne Jacquemier; Sunil R Lakhani; José Palacios; Andrea L Richardson; Stuart J Schnitt; Fernando C Schmitt; Puay-Hoon Tan; Gary M Tse; Sunil Badve; Ian O Ellis
Journal:  Breast Cancer Res       Date:  2010-07-30       Impact factor: 6.466

8.  Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?

Authors:  André Albergaria; Sara Ricardo; Fernanda Milanezi; Vítor Carneiro; Isabel Amendoeira; Daniella Vieira; Jorge Cameselle-Teijeiro; Fernando Schmitt
Journal:  BMC Cancer       Date:  2011-07-15       Impact factor: 4.430

Review 9.  An overview of prognostic factors for long-term survivors of breast cancer.

Authors:  Isabelle Soerjomataram; Marieke W J Louwman; Jacques G Ribot; Jan A Roukema; Jan Willem W Coebergh
Journal:  Breast Cancer Res Treat       Date:  2007-03-22       Impact factor: 4.872

10.  Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis.

Authors:  Zoë E Winters; Russell D Leek; Mike J Bradburn; Chris J Norbury; Adrian L Harris
Journal:  Breast Cancer Res       Date:  2003-10-03       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.